| Rank |
Title |
Year |
PubWeight™‹?› |
|
1
|
Stabilizing the boundary between US politics and science: the role of the Office of Technology Transfer as a boundary organization.
|
1999
|
3.62
|
|
2
|
An agenda for STS: Porter on trust and quantification in science, politics and society. [Review of: Porter TM. Trust in numbers: the pursuit of objectivity in science and public life. Princeton University Press, 1995].
|
1999
|
2.58
|
|
3
|
Code unknown: histories of the gene. [Reviews of: Keller, EF. The century of the gene. Harvard University Press, 2000 and Kay, LE. Who wrote the book of life? A history of the genetic code. Stanford University Press, 2000].
|
2001
|
2.22
|
|
4
|
Medical science in the light of the Holocaust: Departing from a post-war paper by Ludwik Fleck.
|
2008
|
2.00
|
|
5
|
Understanding 'anticipatory governance'.
|
2014
|
1.89
|
|
6
|
Eugenics in Britain.
|
1976
|
1.88
|
|
7
|
Rhetorics of hope and fear in the great embryo debate.
|
1993
|
1.81
|
|
8
|
Neoliberal pharmaceutical science and the Chicago School of Economics.
|
2014
|
1.66
|
|
9
|
Different differences: the use of 'genetic ancestry' versus race in biomedical human genetic research.
|
2011
|
1.63
|
|
10
|
The rise of 'recruitmentology': clinical research, racial knowledge, and the politics of inclusion and difference.
|
2008
|
1.58
|
|
11
|
This view of science: Stephen Jay Gould as historian of science and scientific historian, popular scientist and scientific popularizer.
|
2002
|
1.53
|
|
12
|
The contract research organization and the commercialization of scientific research.
|
2005
|
1.53
|
|
13
|
The matilda effect in science: awards and prizes in the US, 1990s and 2000s.
|
2012
|
1.50
|
|
14
|
Certain uncertainties: modes of patient safety in healthcare.
|
2012
|
1.49
|
|
15
|
Experiences and voices of eugenics field-workers: 'women's work' in biology.
|
1997
|
1.40
|
|
16
|
Eyeballing expertise.
|
2014
|
1.39
|
|
17
|
The value of practice: A critique of interactional expertise.
|
2016
|
1.38
|
|
18
|
The drugs don't work: expectations and the shaping of pharmacogenetics.
|
2003
|
1.24
|
|
19
|
The American Breeders' Association: genetics and eugenics in an agricultural context, 1903-13.
|
1983
|
1.22
|
|
20
|
Ghosts in the machine: publication planning in the medical sciences.
|
2009
|
1.21
|
|
21
|
Sacrifice and the transformation of the animal body into a scientific object: laboratory culture and ritual practice in the neurosciences.
|
1988
|
1.21
|
|
22
|
Science friction: data, metadata, and collaboration.
|
2011
|
1.21
|
|
23
|
The 'Glasgow School' of Paton, Findlay and Cathcart: conservative thought in chemical physiology, nutrition and public health.
|
1989
|
1.20
|
|
24
|
Bio science: genetic genealogy testing and the pursuit of African ancestry.
|
2008
|
1.19
|
|
25
|
The standardization of race and ethnicity in biomedical science editorials and UK biobanks.
|
2008
|
1.14
|
|
26
|
Generating sociability to drive science: patient advocacy organizations and genetics research.
|
2011
|
1.14
|
|
27
|
The biologistical construction of race: 'admixture' technology and the new genetic medicine.
|
2008
|
1.14
|
|
28
|
Voxels in the brain: neuroscience, informatics and changing notions of objectivity.
|
2001
|
1.13
|
|
29
|
Ambivalence, equivocation and the politics of experimental knowledge: a transdisciplinary neuroscience encounter.
|
2014
|
1.12
|
|
30
|
How places matter: telecare technologies and the changing spatial dimensions of healthcare.
|
2012
|
1.10
|
|
31
|
Matters of care in technoscience: assembling neglected things. .
|
2011
|
1.10
|
|
32
|
The British success with penicillin.
|
1987
|
1.08
|
|
33
|
'The formula that killed Wall Street': the Gaussian copula and modelling practices in investment banking.
|
2014
|
1.08
|
|
34
|
The emergence of toxicogenomics: a case study of molecularization.
|
2005
|
1.07
|
|
35
|
The shipwreck of the singular.
|
2014
|
1.07
|
|
36
|
Shaping the intimate: influences on the experience of everyday nerves.
|
2004
|
1.06
|
|
37
|
Negotiating exclusion: MSM, identity, and blood policy in the age of AIDS.
|
2010
|
1.05
|
|
38
|
Scientific work and uncertainty.
|
1985
|
1.00
|
|
39
|
Architectures of genetic medicine: comparing genetic testing for breast cancer in the USA and the UK.
|
2005
|
0.99
|
|
40
|
Race, genetics, and disease: questions of evidence, matters of consequence.
|
2008
|
0.98
|
|
41
|
A black technician and blue babies.
|
2003
|
0.98
|
|
42
|
Medical and biological constraints: early research on variation in bacteriology.
|
1987
|
0.98
|
|
43
|
When humans are the exception: cross-species databases at the interface of biological and clinical research.
|
2012
|
0.97
|
|
44
|
Performing ontology.
|
2015
|
0.96
|
|
45
|
Ontological turns, turnoffs and roundabouts.
|
2015
|
0.96
|
|
46
|
Manufacturing desire: the commodification of female sexual dysfunction.
|
2004
|
0.96
|
|
47
|
The expulsion of the Neanderthals from human ancestry: Marcellin Boule and the social context of scientific research.
|
1982
|
0.96
|
|
48
|
Documenting the doable and doing the documented: bridging strategies at the UK Stem Cell Bank.
|
2011
|
0.96
|
|
49
|
The sciences of subjectivity.
|
2012
|
0.95
|
|
50
|
Stuck with/in a 'turn': Can we metaphorize better in Science and Technology Studies?
|
2015
|
0.95
|